Deborah Weitzman, CEO of the PSS Segment at Cardinal Health Inc (NYSE:CAH), filed a Form 4 on August 20, 2026, reporting the sale of 7,354 common shares across three transactions on August 18, 2026.

Key Highlights

  • Reporting person: Deborah Weitzman, identified in the filing as CEO, PSS Segment of Cardinal Health Inc.
  • Total shares sold: 7,354 common shares disposed of on August 18, 2026, across three separate sale transactions.
  • Transaction prices: Weighted average prices of $235.3, $236.59, and $237.44 per share, respectively, across the three tranches.
  • Price ranges: Individual sales ranged from $235.17 to $237.6285, with each tranche executed in multiple transactions.
  • Remaining ownership: Following the reported transactions, Weitzman directly beneficially owned 77,901 common shares.
  • Transaction code: All three transactions carry code "S," indicating open-market sales, per the filing.

Weitzman's Three-Tranche Share Sale at Cardinal Health

According to the Form 4 filing, Deborah Weitzman sold Cardinal Health common shares in three separate tranches on August 18, 2026. The first tranche consisted of 6,665 shares at a weighted average price of $235.3, with individual transaction prices ranging from $235.17 to $236.02, inclusive. Following that sale, her directly held beneficial ownership stood at 78,590 shares, according to the filing.

The second tranche covered 408 shares at a weighted average price of $236.59, with individual prices ranging from $236.24 to $237.143, inclusive, reducing her direct holdings to 78,182 shares. The third tranche involved 281 shares at a weighted average price of $237.44, with prices ranging from $237.2615 to $237.6285, inclusive, bringing her final reported direct beneficial ownership to 77,901 common shares, the filing stated.

The filing notes that all reported prices in Table I are weighted averages and that Weitzman "undertakes to provide to Cardinal Health, Inc., any security holder of Cardinal Health, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes 1, 2, and 3 to this Form 4." The form was signed by Amanda S. Pashi as attorney-in-fact on August 20, 2026. No derivative securities transactions were reported.

What Was Disclosed

The filing disclosed three open-market sales of Cardinal Health common shares by PSS Segment CEO Deborah Weitzman on August 18, 2026, totaling 7,354 shares at weighted average prices between $235.3 and $237.44, leaving her with 77,901 directly held shares.